Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer
Francesca Jackson-Spence, James Larkin, Poulam Patel, et al.
Nature Medicine
|
June 20, 2020
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
Nature Medicine
|
November 6, 2019
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
European Urology
|
May 16, 2022
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
Bernadett Szabados, Mark Kockx, Zoe June Assaf, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer
Francesca Jackson-Spence, James Larkin, Poulam Patel, et al.
Nature Medicine
|
June 20, 2020
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
Nature Medicine
|
November 6, 2019
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
European Urology
|
May 16, 2022
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
Bernadett Szabados, Mark Kockx, Zoe June Assaf, et al.
Page
of 4